Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Stage 4 and 5 Chronic Kidney Disease
NCT00169923Phase 3Withdrawn
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosiglitazone in chronic kidney disease (CKD), sponsored by Leiden University Medical Center. Planned start Apr 2007; status: withdrawn.
02
Drugs
rosiglitazone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00169923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169923.